Recent Clinical Advances in Pharmacotherapy for Levodopa-Induced Dyskinesia
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent Clinical Advances in Pharmacotherapy for Levodopa-Induced Dyskinesia
Authors
Keywords
-
Journal
DRUGS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-07-23
DOI
10.1007/s40265-019-01170-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Randomized Delayed-Start Trial of Levodopa in Parkinson’s Disease
- (2019) Constant V.M. Verschuur et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacokinetics of ADS-5102 (Amantadine) Extended Release Capsules Administered Once Daily at Bedtime for the Treatment of Dyskinesia
- (2018) Robert A. Hauser et al. CLINICAL PHARMACOKINETICS
- Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson’s Disease
- (2018) Lawrence W. Elmer et al. CNS DRUGS
- Long-term management of Parkinson’s disease using levodopa combinations
- (2018) Thomas Müller et al. EXPERT OPINION ON PHARMACOTHERAPY
- Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial
- (2018) Regina Katzenschlager et al. LANCET NEUROLOGY
- Impact of dyskinesia on activities of daily living in Parkinson's disease: Results from pooled phase 3 ADS-5102 clinical trials
- (2018) Rajesh Pahwa et al. PARKINSONISM & RELATED DISORDERS
- Investigational drugs in Phase I and Phase II for Levodopa-induced dyskinesias
- (2017) Silvia Cerri et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Benefit on motor and non-motor behavior in a specialized unit for Parkinson’s disease
- (2017) Thomas Müller et al. JOURNAL OF NEURAL TRANSMISSION
- The pharmacological and non-pharmacological interventions for the management of fatigue related multiple sclerosis
- (2017) Philippa Miller et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Randomized, placebo-controlled trial of ADS-5102 (amantadine) extended-release capsules for levodopa-induced dyskinesia in Parkinson's disease (EASE LID 3)
- (2017) Wolfgang Oertel et al. MOVEMENT DISORDERS
- Ninety-day Local Tolerability and Toxicity Study of ND0612, a Novel Formulation of Levodopa/Carbidopa, Administered by Subcutaneous Continuous Infusion in Minipigs
- (2017) Yuval Ramot et al. TOXICOLOGIC PATHOLOGY
- ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson’s Disease (EASE LID 2 Study): Interim Results of an Open-Label Safety Study
- (2017) Robert A. Hauser et al. Journal of Parkinsons Disease
- ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study)
- (2017) Rajesh Pahwa et al. JAMA Neurology
- Fatigue Management in Multiple Sclerosis
- (2016) Carmen Tur Current Treatment Options in Neurology
- Amantadine extended release for levodopa-induced dyskinesia in Parkinson's disease (EASED Study)
- (2015) Rajesh Pahwa et al. MOVEMENT DISORDERS
- Medication Adherence in Patients with Parkinson’s Disease
- (2014) Naveed Malek et al. CNS DRUGS
- Pharmacological Strategies for the Management of Levodopa-Induced Dyskinesia in Patients with Parkinson’s Disease
- (2014) Eva Schaeffer et al. CNS DRUGS
- Randomized clinical trial of topiramate for levodopa-induced dyskinesia in Parkinson's disease
- (2014) Christopher Kobylecki et al. PARKINSONISM & RELATED DISORDERS
- Deep Brain Stimulation Induces Striatal Dopamine Release in Obsessive-Compulsive Disorder
- (2013) Martijn Figee et al. BIOLOGICAL PSYCHIATRY
- Withdrawing amantadine in dyskinetic patients with Parkinson disease: The AMANDYSK trial
- (2013) F. Ory-Magne et al. NEUROLOGY
- The PRIPS study: screening battery for subjects at risk for Parkinson's disease
- (2012) D. Berg et al. EUROPEAN JOURNAL OF NEUROLOGY
- Severe gastrointestinal complications in patients with levodopa/carbidopa intestinal gel infusion
- (2012) Fabian Klostermann et al. MOVEMENT DISORDERS
- Impact of complications and comorbidities on treatment costs and health-related quality of life of patients with Parkinson's disease
- (2011) Jan-Philipp Bach et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Impact of Oral Fast Release Amantadine on Movement Performance in Patients with Parkinson’s Disease
- (2011) Siegfried Muhlack et al. Pharmaceutics
- Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE-PD study
- (2010) Fabrizio Stocchi et al. ANNALS OF NEUROLOGY
- Long-term antidyskinetic efficacy of amantadine in Parkinson's disease
- (2010) Elisabeth Wolf et al. MOVEMENT DISORDERS
- Placebo influences on dyskinesia in Parkinson's disease
- (2008) Christopher G. Goetz et al. MOVEMENT DISORDERS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now